Ningxia Qiyuan Pharmaceutical Co., Ltd. has been recognized as a High-Tech Enterprise and operates both a Corporate Technology Center and a Postdoctoral Research Workstation. The company's active pharmaceutical ingredients (APIs)—Erythromycin and Tetracycline Hydrochloride—have obtained certifications from the U.S. FDA, the European COS, and EU GMP, and have successfully passed official quality audits conducted by regulatory bodies in numerous countries, including India and Japan. Additionally, the company's Vitamin C products have received international food certifications such as Halal and Kosher.
Advanced technological features
Environmentally sustainable processes minimizing waste and energy consumption.
Industry 4.0 technologies enabling real-time monitoring and predictive maintenance.
Tailored chemical solutions designed to meet specific customer requirements.
Proven track record scaling laboratory processes to commercial production.
On January 28, 2022, a notice issued by the National Development and Reform Commission and other agencies—regarding the publication of the list of newly recognized (28th Batch) and all existing National Enterprise Technology Centers for 2021—indicated that the Technology Center of Ningxia Qiyuan Pharmaceutical Co., Ltd. has been granted the status of a National Enterprise Technology Center.
Copyright © Ningxia Qiyuan Pharmaceutical Co., Ltd 2026. All right reserved.
